Combinatorial therapeutic enzymes to combat multidrug resistance in bacteria.

Autor: Upadhyay A; Department of Biotechnology, National Institute of Technology, Raipur 492010, CG, India., Pal D; Department of Chemical Engineering, National Institute of Technology, Raipur 492010, CG, India. Electronic address: dpsingh.che@nitrr.ac.in., Kumar A; Department of Biotechnology, National Institute of Technology, Raipur 492010, CG, India. Electronic address: awanik.bt@nitrr.ac.in.
Jazyk: angličtina
Zdroj: Life sciences [Life Sci] 2024 Sep 15; Vol. 353, pp. 122920. Date of Electronic Publication: 2024 Jul 22.
DOI: 10.1016/j.lfs.2024.122920
Abstrakt: Aims: Antibiotic resistance including multidrug resistance (MDR) is a negative symbol to the human health system because it loses the capability to treat infections. Unfortunately, the available antibiotics do not show an effective therapeutic response against bacterial infections. In the situation of global antibiotic unresponsiveness, enzymatic therapy especially in combinatorial form seems an effective approach to control bacterial infection and combat resistance. The article is important because it focuses on combinatorial enzymatic therapy that has multiple properties (effective antibacterial performances, antibiofilm capacity, immunomodulators, targeted actions, synergistic actions, multiple targeting, and resistance-proof properties) and can address antibiotic resistance effectively.
Materials and Methods: We searched the related topics with Pubmed, Scopus, and Google Scholar databases and finally 73 relevant papers were reviewed in detail and cited in this article.
Key Findings: Discusses properties of combinatorial therapeutic enzymes made it an accomplished means over antibiotic therapy. This article discusses the need for combinatorial enzymatic therapy against bacterial infection, its distinguished features, and properties with multi-mechanistic antibacterial action. It discussed the European Medicine Agency and Food and Drug Administration-approved therapeutic enzymes (antibacterial and antibiofilm).
Significance: This article provided the possible combination of the enzyme that may be used as an antibacterial agent along with limitations and future scope of combinatorial antibacterial enzymatic agents. This article could draw the attention of researchers to combinatorial therapeutic enzymatic molecules as effective and futuristic therapy to overcome the problem of multiple antibiotic resistance in bacteria.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: